持续深化资本市场改革，保险开门红景气度上行，非银经营韧性增强

Investment Rating - The report maintains a positive recommendation for the insurance sector, expecting significant growth in new single premium and new business value (NBV) due to favorable market conditions and low-risk preferences among investors [4]. Core Insights - The operating environment for securities companies has significantly improved, with ongoing reforms in capital market financing expected to enhance resilience in both the market and brokerage performance. Key recommendations include focusing on high-quality brokers with valuation mismatches, particularly Guotai Junan and Haitong Securities, as well as companies with strong performance in the technology sector like Sichuan Shuangma [2][4]. - The first version of the commercial health insurance innovative drug directory has been released, including 19 drugs with price reductions of 15%-50%. This marks a significant step in the collaboration between basic medical insurance and commercial insurance, aiming to enhance the attractiveness of commercial insurance and reduce patient costs [3][4]. - The report highlights the importance of the central economic work conference, which emphasizes the need for continued support for key sectors such as technology innovation and small and medium enterprises, alongside deepening reforms in capital market financing [37][43]. Summary by Sections Securities Sector - The central economic work conference has called for continued implementation of moderately loose monetary policies and support for expanding domestic demand and technology innovation. This is expected to enhance the resilience of the capital market and brokerage operations [1][43]. - A series of policies aimed at improving the inclusiveness and adaptability of the capital market have been implemented, which will further support quality enterprises in issuing and listing [1][2]. Insurance Sector - The newly established commercial health insurance innovative drug directory is expected to complement basic medical insurance, potentially increasing the appeal of commercial insurance and alleviating patient financial burdens [3][4]. - The report anticipates a double-digit growth in new single premium and NBV for major insurance companies due to favorable market conditions and the ongoing transformation of dividend insurance [4][30].